Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Methylprednisolone | Experimental | Infiltration of 40 mg of methylprednisolone acetate plus 1 mL of xylocaine |
|
| Placebo | Placebo Comparator | Infiltration of 1 mL of xylocaine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EXPERIMENTAL | Drug | Infiltration of 40 mg of methylprednisolone acetate plus 1 mL of xylocaine and Diclofenac sodium 100 mg PO QD for 10 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| WOMAC score | The WOMAC (Westren Ontario and McMaster Universities) index is used to assess patients with osteoarthritis of the hip or knee using 24 parameters. It can be used to monitor the course of the disease or to determine the effectiveness of anti-rheumatic medications. Pain, Stiffness and Physical functionVisual analogue scale (VAS) may be used ranging from 0 to 10. | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| VAS satisfaction | Visual Analoge Scale for satisfaction | 4 weeks |
| Improvement | Percentage of improvement | 4 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mario Alberto Garza Elizondo, MD | Universidad Autónoma de Nuevo León | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario "José Eleuterio González" | Monterrey | Nuevo León | 66024 | Mexico |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17043509 | Background | Alvarez-Nemegyei J, Canoso JJ. Evidence-Based Soft Tissue Rheumatology IV: Anserine Bursitis. J Clin Rheumatol. 2004 Aug;10(4):205-6. doi: 10.1097/01.rhu.0000135561.41660.b0. | |
| Background | Calvo-Alén J, Rua-Figueroa I, Erausquin C. Anserine bursitis treatment: local corticoesteroid injction against NSAID: a prospective study [Spanish]. Rev Esp Reumatol. 1993;20:13-15. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002062 | Bursitis |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| PLACEBO | Drug | Infiltration of 1 mL of xylocaine and Diclofenac sodium 100 mg PO QD for 10 days |
|
| SAFETY | Pain at infiltration site, ecchymosis, bleeding, paresthesias, skin infection, anaphilaxy, vasovagal reaction | 4 weeks |